1-4 of 4
Ezgi Elmas
Close
Sort by
Journal Articles

CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity

Meisam Naeimi Kararoudi, Yuya Nagai, Ezgi Elmas, Marcelo de Souza Fernandes Pereira, Syed Abbas Ali, Philip Hollingsworth Imus, Darren Wethington, Ivan Marques Borrello, Dean Anthony Lee, Gabriel Ghiaur
Journal: Blood
Blood (2020) 136 (21): 2416–2427.
https://doi.org/10.1182/blood.2020006200
Published: 2020
Includes: Supplemental data
Journal Articles

CD33 Targeting Primary CAR-NK Cells Generated By CRISPR Mediated Gene Insertion Show Enhanced Anti-AML Activity

Meisam Naeimi Kararoudi, PhD DVM, Shibi Likhite, PhD, Ezgi Elmas, Maura Schwartz, Kinnari Sorathia, Kenta Yamamoto, Nitin Chakravarti, PhD, Branden S Moriarity, PhD, Kathrin Meyer, PhD, Dean Anthony Lee, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-142494
Published: 2020
Journal Articles

CD38 Knockout Primary NK Cells to Prevent "Fratricide" and Boost Daratumumab Activity

Yuya Nagai, MD, Meisam Naeimi Kararoudi, PhD DVM, Ezgi Elmas, MS, Marcelo Pereira, Syed Abbas Ali, MD, Philip Hollingsworth Imus, MD, Dean Anthony Lee, MD PhD, Gabriel Ghiaur, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 870.
https://doi.org/10.1182/blood-2019-129456
Published: 2019
Journal Articles

Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells

Meisam Naeimi Kararoudi, PhD DVM, Ezgi Elmas, MS, Margaret Lamb, MD, Nitin Chakravarti, PhD, Prashant Trikha, PhD, Dean Anthony Lee, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5687.
https://doi.org/10.1182/blood-2018-99-116621
Published: 2018